Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Magnetic Resonance Spectroscopy 4 Biopsy 3 X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 regorafenib 1 pembrolizumab 1 erdafitinib 1 ensartinib 1 cabozantinib 1 alectinib 1 aflibercept 1 Surveys and Questionnaires 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 ONC206 1 Nivolumab 1 NEO212 1 Lomustine 1 Ipilimumab 1 IFL protocol 1 Gadolinium 1 Ferrosoferric Oxide 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡